Takimoto Chris H 4
4 · IGM Biosciences, Inc. · Filed Dec 1, 2023
Insider Transaction Report
Form 4
Takimoto Chris H
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-11-29$6.21/sh−1,180$7,331→ 53,562 total
Footnotes (2)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.79 to $6.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.